Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
XenoGesis
XenoGesis
Activities:
Research & Development
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Drug Delivery
Quay Pharma partners with XenoGesis on drug development
The partnership aims to accelerate the drug development process for both companies’ clients
Research & Development
Contract research organisation XenoGesis expands services
Nottingham, UK-based firm adds CYP induction and gene expression assay services to portfolio
Research & Development
XenoGesis aims to expand into US market
Appoints Sabrina Mogle as a business development specialist to spearhead growth in the region
Research & Development
XenoGesis strengthens DMPK team with appointment of Peter White
He specialises in mass spectrometry and bioanalysis
Research & Development
XenoGesis invests in new cutting-edge technology
Will allow the DMPK and bioanalysis specialist to increase capacity and add new capabilities
Research & Development
XenoGesis appoints Director of External Projects
Graham Trevitt joins the Nottingham, UK-based contract research organisation
Research & Development
UK companies Molecular Profiles and XenoGesis forge partnership
Nottingham-based companies will support drug developers during pre-clinical and formulation stages
Subscribe now